Meet with us at MassBio’s R&D Reimagined – Advanced Modalities event, designed for biotech and pharma R&D leaders who are advancing cell and gene therapies, RNA-based therapeutics, protein and peptide engineering, and other next-generation platforms. Genezen’s Chief Technical and Chief Commercial Officer, Susan D’Costa will participate in this exciting discussion.
Highlights include:
• Candid discussions and real-world biotech and pharma R&D case studies
• Strategies to accelerate development and reduce risk in scale-up
• Insights into delivery, analytics, CMC, quality, and supply chain challenges shaping advanced modalities
• Extensive networking time and opportunities for 1:1 partnering meetings
Apply to attend directly through MassBio’s event site: https://www.massbio.org/events/rd-reimagined-advanced-modalities/
Let’s talk! Complete the form below to schedule time with us at this exciting event and ensure a dedicated discussion.
We welcome the opportunity to learn more about your advanced modality program and explore how we can support your next milestone.
